Advanced AI-discovery platform Imagia EVIDENS™ to link analysis of genomic data to patient outcomes for reproducible data-driven precision medicine research MONTRÉAL –  Imagia, a leading healthcare AI company that unites healthcare expertise and advanced artificial intelligence technology, and Illumina, a global leader in DNA sequencing and analysis, today announced a partnership to investigate how genomics, clinical data and imaging will […]

Company launches Q Line sequencing portfolio for users in regulated settings  Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulated markets. Products for customers in regulated environments  Q line, launched today, is designed to support users who wish to develop tests based on nanopore sequencing, for deployment in their own environments. The ISO9001-qualified Q […]

Comprehensive Panel Designed to Provide Molecular Characterization of Aggressive Lymphomas TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the pre-launch introduction of its new HTG EdgeSeq Pan B-Cell Lymphoma Panel, which is expected to be commercially available for purchase in kit […]

Eurofins Technologies, a supplier of test kits and systems for laboratory analyses, announces that its ELISA assay (enzyme-linked immunosorbent assay) for the detection of gluten, SENSISpec Ingezim Gluten R5, has been granted AOAC Research Institute Performance Tested MethodsSM status (AOAC Cert. No. 052005) for use with gluten-free bread, oat flour and stainless steel surfaces. The assay was developed by Eurofins Ingenasa, a biotechnology […]

Vienna, Austria, and San Diego, CA, USA, June 17, 2020 – Lexogen, a transcriptomics and Next Generation Sequencing company, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis and collaboration tools, announced availability for the QuantSeq 3’ mRNA-Seq data analysis pipeline on ROSALIND™, the globally recognized discovery platform for scientists and researchers. The partnership enhances QuantSeq 3’ […]

GSv9™ is Lonza’s newly launched chemically defined media and feeds platform, specifically developed to enhance the performance of the GS Gene Expression System® for optimized recombinant protein production The GSv9™ Media, Feeds and Operating parameters are simple to implement and highly robust, maximizing product yields and improving consistency to meet the scalability needs of biopharmaceutical […]

ST. LOUIS — OpenCell Technologies, an R&D-stage biomedical venture, has announced the hiring of Kevin Gutshall as CEO. Kevin leaves his role as MilliporeSigma’s director of life science business development and M&A focusing on the cell and gene therapy business unit, to join OpenCell and lead its efforts to translate and commercialize its core technology platform, POROS. OpenCell was […]

To learn more about Canopy’s data analysis offerings, please browse the Canopy website. St. Louis, MO—Canopy Biosciences, a multi-omic CRO providing NanoString® nCounter® and RNA Seq services to both clinical and research customers, has partnered with Onramp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy’s gene expression services.  Launched earlier this year, Canopy […]

Fluidigm to Be Exclusive Distributor for Bethyl Antibodies for Use with Imaging Mass Cytometry Providing Researchers with Expanded Capabilities in Interrogating the Tissue Microenvironment SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration with Bethyl Laboratories to provide […]